Latest News

Results from the ICON8 trial show that, for women with ovarian cancer, having chemotherapy every week is no better at preventing the cancer coming back or getting worse than having it every three weeks.

On Thursday 28 November 2019, we'll be running a Twitter Q&A session about the RADICALS trial and the ARTISTIC meta-analysis - with the hashtag #ProstateRadiotherapy. The purpose of the Twitter Q&A is to raise awareness of prostate cancer research. Prostate cancer accounts for around one fifth of all male cancers. In the UK there are around 47,000 new cases each year ...

MRC CTU at UCL staff to present analyses from the STREAM tuberculosis trial
Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days
SORCE recruited 1711 patients with kidney cancer after they had surgery to remove their cancer.